Your account is not claimed yet. You can sign up with ORCID to claim your account.

Gavin MacBeath

Years Active: 2019-2021
Publications (10 Years): 2

TScan Therapeutics

Scripps Research Institute (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

TScan Therapeutics Dec 5o 2018

United States

Chief Scientific Officer

Education History

Scripps Research Institute

United States

PHD :: Macromolecular and Cellular Structure and Chemistry

Publications

Giacomo Oliveira, Kari Stromhaug, Susan Klaeger, Tomasz Kula, Dennie T Frederick, Phuong M Le, Juliet Forman, Teddy Huang, Shuqiang Li, Wandi Zhang, Qikai Xu, Nicoletta Cieri, Karl R Clauser, Sachet A Shukla, Donna S Neuberg, Sune Justesen, Gavin MacBeath, Steven A Carr, Edward F Fritsch, Nir Hacohen, Moshe Sade-Feldman, Kenneth J Livak, Genevieve M Boland, Patrick A Ott, Derin B Keskin, Catherine J Wu
Phenotype, specificity and avidity of antitumour CD8+ T cells in melanoma. Nature 596 (7870) (2021)
Jessica B Casaletto, Melissa L Geddie, Adnan O Abu-Yousif, Kristina Masson, Aaron Fulgham, Antoine Boudot, Tim Maiwald, Jeffrey D Kearns, Neeraj Kohli, Stephen Su, Maja Razlog, Andreas Raue, Ashish Kalra, Maria Håkansson, Derek T Logan, Martin Welin, Shrikanta Chattopadhyay, Brian D Harms, Ulrik B Nielsen, Birgit Schoeberl, Alexey A Lugovskoy, Gavin MacBeath
MM-131, a bispecific anti-Met/EpCAM mAb, inhibits HGF-dependent and HGF-independent Met signaling through concurrent binding to EpCAM. Proceedings of the National Academy of Sciences of the United States of America 116 (15) (2019)

Gavin MacBeath.css-eqlu8i{font-size:small;padding-left:4px;}